TARDBP and amyotrophic lateral sclerosis: In this systematic review and meta-analysis, we evaluated the usefulness of CSF TDP-43 as a biomarker of ALS by analyzing results from seven studies, including a total of 472 individuals, 254 patients with ALS and 198 controls.